Zhanyang Qian | Neuroscience | Research Excellence Award

Published on by Innovation Technologist

Dr. Zhanyang Qian | Neuroscience | Research Excellence Award

Nantong University | China

Dr. Zhanyang Qian is a neural regeneration scientist specializing in innovative therapeutic strategies for spinal cord injury, with a strong focus on immunomodulation, neuroinflammation, and cellular repair mechanisms. His research integrates advanced molecular immunology, mitochondrial biology, and translational animal models to uncover pathways that drive neural protection and functional recovery. He has secured multiple national-level grants and prestigious provincial talent recognitions, reflecting his rapidly rising impact in the field. Dr. Qian has authored a robust portfolio of high-impact publications, including several first- and corresponding-author papers in top-tier journals, with his work cited by leading neuroscience outlets. His studies have advanced understanding of microglial and astrocytic responses, efferocytosis in senescent macrophages, and mitophagy-driven neuroprotection, contributing valuable insights to the development of targeted interventions for central nervous system injury. Beyond research, he contributes to the scientific community as a committee member in neurological regeneration, serves on an editorial board, and reviews for reputable journals. Dr. Qian is recognized for his leadership in pioneering mechanistic discoveries and translating them toward clinically relevant therapeutic strategies, positioning him as an emerging expert in spinal cord injury repair and neural regeneration.

Profiles: Scopus | Orcid

Featured Publications

Xia, M., Li, C., Zhang, Y., Wang, T., Zhang, C., Zhou, J., Zhu, X., Hong, H., Li, H., Qian, Z., et al. (2025). GLP-1R activation restores Gas6-driven efferocytosis in senescent foamy macrophages to promote neural repair. Redox Biology, 103857.

Xia, M., Li, C., Chen, J., Wu, C., Zhang, J., Hong, H., Jiang, J., Xu, G., Qian, Z., & Cui, Z. (2025). Activation of FANCC attenuates mitochondrial ROS-driven necroptosis by targeting TBK1-dependent mitophagy in astrocytes after spinal cord injury. Theranostics.

Qian, Z., Li, R., Zhao, T., Xie, K., Li, P., Li, G., Shen, N., Gong, J., Hong, X., & Yang, L., et al. (2024). Blockade of the ADAM8–Fra-1 complex attenuates neuroinflammation by suppressing the Map3k4/MAPKs axis after spinal cord injury. Cellular & Molecular Biology Letters, 29, Article 589.

Qian, Z., Xia, M., Zhao, T., Li, Y., Li, G., Zhang, Y., Li, H., & Yang, L. (2024). ACOD1, rather than itaconate, facilitates p62-mediated activation of Nrf2 in microglia post spinal cord contusion. Clinical and Translational Medicine, 14, Article e1661.

Chang, J., Qian, Z., Wang, B., Cao, J., Zhang, S., Jiang, F., Kong, R., Yu, X., Cao, X., & Yang, L., et al. (2023). Transplantation of A2 type astrocytes promotes neural repair and remyelination after spinal cord injury. Cell Communication and Signaling, 21(1).

Jayantee Kalita | Neurology | Best Researcher Award

Published on by Innovation Technologist

Prof. Jayantee Kalita | Neurology | Best Researcher Award

Professor & Head at Sanjay Gandhi Post Graduate Institute of Medical Sciences | India

Prof. Jayantee Kalita is a highly accomplished neurologist and academic leader, globally recognized for her extensive research in infectious and vascular neurological disorders. With 509 scientific publications, 12,712 citations from 9,307 documents, and an impressive h-index of 57, she stands among the most influential neuroscientists in India and beyond. Her pioneering studies have advanced understanding of Japanese encephalitis, stroke, status epilepticus, and other major neurological diseases, shaping diagnostic and therapeutic approaches worldwide. A Fellow of multiple prestigious academies, including the National Academy of Medical Sciences, the Indian Academy of Neurology, the American Academy of Neurology, the European Academy of Neurology, and the Royal College of Physicians, Prof. Kalita’s contributions bridge both clinical excellence and academic innovation. She has held leading academic roles at the Sanjay Gandhi Postgraduate Institute of Medical Sciences, mentoring generations of neurologists and fostering cutting-edge research. Her work, supported by premier agencies such as the Indian Council of Medical Research and the Council of Science and Technology (U.P.), is published in top-tier journals including Neurology, Epilepsy Research, and the Journal of Clinical Medicine. Consistently listed among the top 2% of scientists in the world by Stanford University, Prof. Kalita combines research brilliance with a strong sense of social responsibility – actively engaging in community neurological health initiatives, rural outreach, and medical education – making her a leading figure in advancing neurological science and public health.

Profile: Scopus | Google Scholar

Featured Publications

  • A., B., & C. (2025). Effect of high-rate repetitive transcranial magnetic stimulation on phonophobia and brainstem auditory evoked potential in migraine. Molecular Neurobiology.

  • A., B., C., D., & E. (2025). Circulating metabolomic changes in Lennox-Gastaut syndrome: Correlation with clinico-radiological severity. Neurochemistry International.

  • A., B., C., D., & E. (2025). Effect of intravenous immunoglobulin or plasmapheresis in myasthenic crisis and worsening myasthenia gravis compared to without rescue treatment. Clinical Therapeutics.

  • A., B., C., D., …, & E. (2025). Outcome of cerebral venous thrombosis requiring mechanical ventilation. Journal of Clinical Medicine.

  • A., B., & C. (2025). Azathioprine-induced veno-occlusive hepatotoxicity in a patient with myasthenia gravis. Current Drug Safety.